Mutations of KRAS and TP53 in a minor proportion of opisthorchis viverrini-associated cholangiocarcinomas in a hamster model

Asian Pacific Journal of Cancer Prevention

Volumn 9, Issue 1, 2008, Pages 101-106

  Tangkawattana, Sirikachorn ^a,b   Kaewkes, Sasithorn ^a,b   Pairojkul, Chawalit ^a,b   Tangkawattana, Prasarn ^b   Sripa, Banchob ^a,b  

^a KHON KAEN UNIVERSITY   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

Author keywords

Cholangiocarcinoma; Hamster; KRAS; Mutations; Opisthorchis viverrini; TP53

Indexed keywords

EID: 58349110844     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Bos JL (1989) Ras oncogene in human cancer: a review. Cancer Res, 49, 4682-9.
2. Bosan WS, Shank RC, MacEwen JD, et al (1987). Methylation of DNA guanine during the course of induction of liver cancer in hamsters by hydrazine or dimethylnitrosamine. Carcinogenesis, 8, 439-44.
3. Cerny WL, Mangold KA, Scarpelli DG (1990). Activation of K-ras in transplantable pancreatic ductal adenocarcinomas of Syrian golden hamsters. Carcinogenesis, 11, 2075-9.
4. Cerny WL, Mangold KA, Scarpelli DG (1992) K-ras mutation is an early event in pancreatic duct carcinogenesis in the Syrian golden hamster. Cancer Res, 52, 4507-13.
5. Chang KW, Lin SC, Koos S, et al (1996). p53 and Ha-ras mutations in chemically induced hamster buccal pouch carcinomas. Carcinogenesis, 17, 595-600.
6. Chang KW, Mangold KA, Hubchak S, et al (1994). Genomic p53 mutation in a chemically induced hamster pancreatic ductal adenocarcinoma. Cancer Res, 54, 3878-83.
7. Erill N, Cuatrecasas M, Sancho FJ, et al (1996) K-ras and p53 mutations in hamster pancreatic ductal adenocarcinomas and cell lines. Am J Pathol, 149, 1333-9.
8. Friedler A, Hansson LO, Veprintsev DB, et al (2002). A peptide that binds and stabilizes p53 core domain: chaperone strategy for rescue of oncogenic mutants. Proc Natl Acad Sci USA, 99, 937-42.
9. Fujii T, Harada K, Katayanagi K, (2005). Intrahepatic cholangiocarcinoma with multicystic, mucinous appearance and oncocytic change. Pathol Int, 55, 206-9.
10. Hall BE, Bar-Sagi D, Nassar N (2002). The structural basis for the transition from Ras-GTP to Ras-GDP. Proc Natl Acad Sci U S A, 99, 12138-42.
11. Harris CC (1996). Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. J Natl Cancer Inst, 88, 1442-55.
12. Hesketh R (1994) The Oncogene Handbook. Academic Press, London, p225-34.
13. Jinawath N, Chamgramol Y, Furukawa Y, et al (2006). Comparison of gene-expression profiles between Opisthorchis viverrini- and non-Opisthorchis viverrini-associated intrahepatic cholangiocarcinoma. Hepatology, 44, 1025-38.
14. Kang YK, Kim WH, Lee HW, et al (1999). Mutation of p53 and K-ras, and loss of heterozygosity of APC in intrahepatic cholangiocarcinoma. Lab Invest, 79, 477-83.
15. Kato S, Han SY, Liu W, et al (2003) Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis. Proc Natl Acad Sci U S A, 100, 8424-9.
16. Khan SA, Thomas HC, Toledano MB, et al (2005). p53 Mutations in human cholangiocarcinoma: a review. Liver Int, 25, 704-16.
17. Kiba T, Tsuda H, Pairojkul C, et al (1993). Mutations of the p53 tumor suppressor gene and the ras gene family in intrahepatic cholangiocellular carcinomas in Japan and Thailand. Mol Carcinog, 8, 312-8.
18. Kyrtopoulos SA (1998). DNA adducts in humans after exposure to methylating agents. Mut. Res, 405, 135-43.
19. Legros Y, McIntyre P, Soussi T (1992). The cDNA cloning and immunological characterization of hamster p53. Gene, 112, 247-50.
20. Levi S, Urbano-Ispizua A, Gill R, et al (1991). Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res, 51, 3497-502.
21. Loeppky RN (1994). Nitrosamine and N-nitroso compound chemistry and biochemistry: advances and perspectives. In: Nitrosamines and related N-nitroso compounds. Eds Loeppky RN and Michejda CJ, American Chemical Society, Washington DC, p1-18.
22. Majima T, Tsujiuchi T, Tsutsumi M, et al (1997). Mutations of K-ras but not p53 genes in biliary duct and pancreatic duct carcinomas induced in hamsters by cholecystoduodenostomy with dissection of the common duct followed by N-nitrosobis (2-oxopropyl)amine. Cancer Lett, 118, 47-53.
23. Mangold KA, Hubchak S, Mangino MM, et al (1994). In vitro carcinogenesis of hamster pancreatic duct cells: cellular and molecular alterations. Carcinogenesis, 15, 1979-84.
24. Mapelli V, Fantinato S, Accardo E, et al (2005). Structure-based hypothesis on active role of RasGEF aG-helix [Abstract]. FEBS Journal 272(s1), E4-006 [serial online].
25. Ohashi K, Tstsumi M, Nakajima Y, et al (1996). Ki-ras point mutations and proliferation activity in biliary tract carcinomas. Br J Cancer, 74, 930-5.
26. Petmitr S, Pinlaor S, Thousungnoen A, et al (1998). K-ras oncogene and p53 gene mutations in cholangiocarcinoma from Thai patients. Southeast Asian J Trop Med Public Health, 29, 71-5.
27. Sherbet GV, Lakshmi MS (1997). Oncogenes and cancer metastasis. In: Genetics of Cancer. Eds Sherbet GV and Lakshmi MS, Academic Press, San Diego. p. 144-54.
28. Sripa B (2003). Pathobiology of opisthorchiasis: an update. Acta Trop, 88, 209-20.
29. Sripa B, Kaewkes S, Sithithaworn P, et al (2007). Liver fluke induces cholangiocarcinoma. PLoS Medicine, 4, 1148-55.
30. Tada M, Omata M, Ohto M (1992). High incidence of ras gene mutation in intrahepatic cholangiocarcinoma. Cancer, 69, 1115-8.
31. Thamavit W, Bhamarapravati N, Sahaphong S, et al (1978). Effects of dimethylnitrosamine on induction of cholangiocarcinoma in Opisthorchis viverrini infected Syrian golden hamsters. Cancer Res, 38, 4634-9.
32. Thamavit W, Kongkanuntn R, Tiwawech D, et al (1987). Level of Opisthorchis infestation and carcinogen dose-dependence of cholangiocarcinoma induction in Syrian golden hamsters. Virchows Arch B Cell Pathol Incl Mol Pathol, 54, 52-8.
33. Tsuda H, Satarug S, Bhudhisawasdi V, et al (1992). Cholangiocarcinomas in Japanese and Thai patients: difference in etiology and incidence of point mutation of the c-Ki-ras proto-oncogene. Mol Carcinog, 6, 266-9.
34. van Kranen HJ, Vermeulen E, Schoren L, et al (1991) Activation of c-K-ras is frequent in pancreatic carcinomas of Syrian hamsters, but is absent in pancreatic tumors of rats. Carcinogenesis, 12, 1477-82.
35. Vatanasapt V, Sripa B, Sithithaworn P, et al (1999). Liver flukes and liver cancer. Cancer Surv, 33, 313-43.
36. Vogelstein B, Kinzler KW (1992). p53 function and dysfunction. Cell, 70, 523-6.
37. Wattanasirichaigoon S, Tasanakhajorn U, Jesadapatarakul S (1998). The incidence of K-ras codon 12 mutations in cholangiocarcinoma detected by polymerase chain reaction technique. J Med Assoc Thai, 81, 316-23.
38. Yamanaka S, Tomioka T, Tajima Y, et al (1997). K-ras gene mutations in intrahepatic bile duct tumors of Syrian golden hamsters. J Surg Oncol, 66, 97-103.